Bill Maughan
Stock Analyst at Clear Street
(0.15)
# 4,280
Out of 4,918 analysts
16
Total ratings
22.22%
Success rate
-38.64%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Bill Maughan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRYS Krystal Biotech | Initiates: Buy | $190 | $156.98 | +21.03% | 1 | Jul 1, 2025 | |
| CRSP CRISPR Therapeutics AG | Downgrades: Hold | $45 | $56.09 | -19.77% | 1 | Jun 27, 2025 | |
| YMAB Y-mAbs Therapeutics | Maintains: Buy | $26 | $4.53 | +473.95% | 2 | Aug 13, 2024 | |
| NKTX Nkarta | Maintains: Buy | $16 → $15 | $2.12 | +607.55% | 2 | May 10, 2024 | |
| FATE Fate Therapeutics | Maintains: Buy | $11 → $9 | $1.07 | +741.12% | 1 | May 10, 2024 | |
| IMCR Immunocore Holdings | Maintains: Hold | $63 → $67 | $33.11 | +102.36% | 3 | May 9, 2024 | |
| MRNA Moderna | Maintains: Hold | $91 → $106 | $27.61 | +283.99% | 3 | May 3, 2024 | |
| IPSC Century Therapeutics | Maintains: Buy | $22 → $24 | $0.53 | +4,412.13% | 1 | Mar 15, 2024 | |
| BCYC Bicycle Therapeutics | Reiterates: Buy | $60 | $8.11 | +639.83% | 1 | Feb 21, 2024 | |
| MRUS Merus | Initiates: Buy | $45 | $65.57 | -31.37% | 1 | Nov 2, 2023 |
Krystal Biotech
Jul 1, 2025
Initiates: Buy
Price Target: $190
Current: $156.98
Upside: +21.03%
CRISPR Therapeutics AG
Jun 27, 2025
Downgrades: Hold
Price Target: $45
Current: $56.09
Upside: -19.77%
Y-mAbs Therapeutics
Aug 13, 2024
Maintains: Buy
Price Target: $26
Current: $4.53
Upside: +473.95%
Nkarta
May 10, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $2.12
Upside: +607.55%
Fate Therapeutics
May 10, 2024
Maintains: Buy
Price Target: $11 → $9
Current: $1.07
Upside: +741.12%
Immunocore Holdings
May 9, 2024
Maintains: Hold
Price Target: $63 → $67
Current: $33.11
Upside: +102.36%
Moderna
May 3, 2024
Maintains: Hold
Price Target: $91 → $106
Current: $27.61
Upside: +283.99%
Century Therapeutics
Mar 15, 2024
Maintains: Buy
Price Target: $22 → $24
Current: $0.53
Upside: +4,412.13%
Bicycle Therapeutics
Feb 21, 2024
Reiterates: Buy
Price Target: $60
Current: $8.11
Upside: +639.83%
Merus
Nov 2, 2023
Initiates: Buy
Price Target: $45
Current: $65.57
Upside: -31.37%